{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T20:00:32Z","timestamp":1781812832090,"version":"3.54.5"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T00:00:00Z","timestamp":1594252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["815026"],"award-info":[{"award-number":["815026"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M590640"],"award-info":[{"award-number":["2016M590640"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Project of Postdoctoral Innovation of Shandong Province","award":["201501010"],"award-info":[{"award-number":["201501010"]}]},{"name":"The Project of Postdoctoral Innovation of Shandong Province","award":["201601006"],"award-info":[{"award-number":["201601006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Platinum-based chemotherapy is recommended as the standard treatment for metastatic esophageal cancer (EC) patients; however, the outcome is poor. Oligometastasis is less aggressive and has limited growth potential. However, the prognostic factors for EC patients with oligometastases was largely unknown. Thus, we intend to determine the prognostic factors, and develop and validate nomograms for prediction of survival for EC patients with oligometastases. In this study, characteristics of 273 oligometastatic EC patients were analyzed using univariate and multivariate Cox models to determine the independent prognostic factors for progression-free survival (PFS) and overall survival (OS). The result showed that history of alcohol consumption, longer tumor, no local radiotherapy for EC, and no local treatment for metastases were independent factors for PFS. Sex, esophageal fistula, number of metastatic organs, and local radiotherapy for EC were independent prognostic factors for OS. On the basis of Cox models, the respective nomogram for prediction of PFS and OS was established with the corrected concordance index of 0.739 and 0.696 after internal cross-validation. In conclusion, local treatment for metastases and local radiotherapy for EC were demonstrated to be beneficial for oligometastatic EC patients, and the validated nomograms are valuable in prognosis prediction and could guide individualized management for these patients.<\/jats:p>","DOI":"10.1038\/s41598-020-68160-6","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T10:06:38Z","timestamp":1594289198000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases"],"prefix":"10.1038","volume":"10","author":[{"given":"Butuo","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiubin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0011-9493","authenticated-orcid":false,"given":"Jinming","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,9]]},"reference":[{"key":"68160_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"68160_CR2","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1093\/annonc\/mdp069","volume":"20","author":"S Lorenzen","year":"2009","unstructured":"Lorenzen, S. et al. Cetuximab plus cisplatin-5-fluorouracil versus cisplatin-5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie. Ann. Oncol. Off. J. Eur. Soc. Med. Oncol. 20, 1667\u20131673. https:\/\/doi.org\/10.1093\/annonc\/mdp069 (2009).","journal-title":"Ann. Oncol. Off. J. Eur. Soc. Med. Oncol."},{"key":"68160_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1442-2050.2010.01069.x","volume":"23","author":"T Tanaka","year":"2010","unstructured":"Tanaka, T. et al. Outcomes of multimodality therapy for stage IVB esophageal cancer with distant organ metastasis (M1-Org). Dis. Esophagus Off. J. Int. Soc. Dis. Esophagus 23, 646\u2013651. https:\/\/doi.org\/10.1111\/j.1442-2050.2010.01069.x (2010).","journal-title":"J. Int. Soc. Dis. Esophagus"},{"key":"68160_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/jco.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman, S. & Weichselbaum, R. R. Oligometastases. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 13, 8\u201310. https:\/\/doi.org\/10.1200\/jco.1995.13.1.8 (1995).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"68160_CR5","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nrclinonc.2011.44","volume":"8","author":"RR Weichselbaum","year":"2011","unstructured":"Weichselbaum, R. R. & Hellman, S. Oligometastases revisited. Nat. Rev. Clin. Oncol. 8, 378\u2013382. https:\/\/doi.org\/10.1038\/nrclinonc.2011.44 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"68160_CR6","doi-asserted-by":"publisher","first-page":"8491","DOI":"10.18632\/oncotarget.3455","volume":"6","author":"DK Reyes","year":"2015","unstructured":"Reyes, D. K. & Pienta, K. J. The biology and treatment of oligometastatic cancer. Oncotarget 6, 8491\u20138524. https:\/\/doi.org\/10.18632\/oncotarget.3455 (2015).","journal-title":"Oncotarget"},{"key":"68160_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1200\/jop.2017.026500","volume":"14","author":"SJ Stephens","year":"2018","unstructured":"Stephens, S. J., Moravan, M. J. & Salama, J. K. Managing patients with oligometastatic non-small-cell lung cancer. J. Oncol. Pract. 14, 23\u201331. https:\/\/doi.org\/10.1200\/jop.2017.026500 (2018).","journal-title":"J. Oncol. Pract."},{"key":"68160_CR8","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1038\/sj.bjc.6601364","volume":"89","author":"MB Polee","year":"2003","unstructured":"Polee, M. B. et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br. J. Cancer 89, 2045\u20132050. https:\/\/doi.org\/10.1038\/sj.bjc.6601364 (2003).","journal-title":"Br. J. Cancer"},{"key":"68160_CR9","first-page":"4123","volume":"33","author":"WW Chen","year":"2013","unstructured":"Chen, W. W. et al. Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy. Anticancer Res. 33, 4123\u20134128 (2013).","journal-title":"Anticancer Res."},{"key":"68160_CR10","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.jtho.2017.03.026","volume":"12","author":"DM Guttmann","year":"2017","unstructured":"Guttmann, D. M. et al. Improved overall survival with aggressive primary tumor radiotherapy for patients with metastatic esophageal cancer. J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer 12, 1131\u20131142. https:\/\/doi.org\/10.1016\/j.jtho.2017.03.026 (2017).","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"68160_CR11","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/jco.2014.56.6661","volume":"33","author":"W Liang","year":"2015","unstructured":"Liang, W. et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 33, 861\u2013869. https:\/\/doi.org\/10.1200\/jco.2014.56.6661 (2015).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"68160_CR12","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1002\/cam4.1224","volume":"6","author":"S Li","year":"2017","unstructured":"Li, S., Zhao, J., Zhu, L., Su, F. & Chen, K. Development and validation of a nomogram predicting the overall survival of stage IV breast cancer patients. Cancer Med. 6, 2586\u20132594. https:\/\/doi.org\/10.1002\/cam4.1224 (2017).","journal-title":"Cancer Med."},{"key":"68160_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.eururo.2016.09.042","volume":"71","author":"A Necchi","year":"2017","unstructured":"Necchi, A. et al. Nomogram-based prediction of overall survival in patients with metastatic urothelial carcinoma receiving first-line platinum-based chemotherapy: retrospective international study of invasive\/advanced cancer of the urothelium (RISC). Eur. Urol. 71, 281\u2013289. https:\/\/doi.org\/10.1016\/j.eururo.2016.09.042 (2017).","journal-title":"Eur. Urol."},{"key":"68160_CR14","doi-asserted-by":"publisher","first-page":"e55834","DOI":"10.1371\/journal.pone.0055834","volume":"8","author":"IC Wu","year":"2013","unstructured":"Wu, I. C. et al. Substance use (alcohol, areca nut and cigarette) is associated with poor prognosis of esophageal squamous cell carcinoma. PLoS ONE 8, e55834. https:\/\/doi.org\/10.1371\/journal.pone.0055834 (2013).","journal-title":"PLoS ONE"},{"key":"68160_CR15","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.2147\/ott.s104182","volume":"9","author":"P Sun","year":"2016","unstructured":"Sun, P. et al. Combined heavy smoking and drinking predicts overall but not disease-free survival after curative resection of locoregional esophageal squamous cell carcinoma. OncoTargets Ther. 9, 4257\u20134264. https:\/\/doi.org\/10.2147\/ott.s104182 (2016).","journal-title":"OncoTargets Ther."},{"key":"68160_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5301\/jbm.2011.8737","volume":"27","author":"J Radojicic","year":"2012","unstructured":"Radojicic, J., Zaravinos, A. & Spandidos, D. A. HPV, KRAS mutations, alcohol consumption and tobacco smoking effects on esophageal squamous-cell carcinoma carcinogenesis. Int. J. Biol. Markers 27, 1\u201312. https:\/\/doi.org\/10.5301\/jbm.2011.8737 (2012).","journal-title":"Int. J. Biol. Markers"},{"key":"68160_CR17","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.athoracsur.2010.11.011","volume":"91","author":"BY Wang","year":"2011","unstructured":"Wang, B. Y., Goan, Y. G., Hsu, P. K., Hsu, W. H. & Wu, Y. C. Tumor length as a prognostic factor in esophageal squamous cell carcinoma. Ann. Thorac. Surg. 91, 887\u2013893. https:\/\/doi.org\/10.1016\/j.athoracsur.2010.11.011 (2011).","journal-title":"Ann. Thorac. Surg."},{"key":"68160_CR18","first-page":"5008","volume":"8","author":"MQ Ma","year":"2015","unstructured":"Ma, M. Q. et al. Is tumor length a prognostic indicator for esophageal squamous cell carcinoma? A single larger study among Chinese patients. Int. J. Clin. Exp. Pathol. 8, 5008\u20135016 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"68160_CR19","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1200\/jco.2011.38.8751","volume":"30","author":"P Bohanes","year":"2012","unstructured":"Bohanes, P. et al. Influence of sex on the survival of patients with esophageal cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 30, 2265\u20132272. https:\/\/doi.org\/10.1200\/jco.2011.38.8751 (2012).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"68160_CR20","first-page":"7212","volume":"50","author":"H Ueo","year":"1990","unstructured":"Ueo, H. et al. Inhibitory effects of estrogen on the growth of a human esophageal carcinoma cell line. Cancer Res. 50, 7212\u20137215 (1990).","journal-title":"Cancer Res."},{"key":"68160_CR21","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/MCP.0b013e3283390de8","volume":"16","author":"AN Rodriguez","year":"2010","unstructured":"Rodriguez, A. N. & Diaz-Jimenez, J. P. Malignant respiratory-digestive fistulas. Curr. Opin. Pulm. Med. 16, 329\u2013333. https:\/\/doi.org\/10.1097\/MCP.0b013e3283390de8 (2010).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"68160_CR22","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.7150\/jca.27579","volume":"9","author":"M Liu","year":"2018","unstructured":"Liu, M., Wang, C., Gao, L., Lv, C. & Cai, X. A nomogram to predict long-time survival for patients with M1 diseases of esophageal cancer. J. Cancer 9, 3986\u20133990. https:\/\/doi.org\/10.7150\/jca.27579 (2018).","journal-title":"J. Cancer"},{"key":"68160_CR23","doi-asserted-by":"publisher","first-page":"v50","DOI":"10.1093\/annonc\/mdw329","volume":"27","author":"F Lordick","year":"2016","unstructured":"Lordick, F., Mariette, C., Haustermans, K., Obermannov\u00e1, R. & Arnold, D. Oesophageal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 27, v50\u2013v57 (2016).","journal-title":"Ann. Oncol."},{"key":"68160_CR24","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.radonc.2017.08.032","volume":"126","author":"M Trovo","year":"2018","unstructured":"Trovo, M. et al. Radical radiation therapy for oligometastatic breast cancer: results of a prospective phase II trial. Radiother. Oncol. 126, 177\u2013180. https:\/\/doi.org\/10.1016\/j.radonc.2017.08.032 (2018).","journal-title":"Radiother. Oncol."},{"key":"68160_CR25","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2018.06.105","volume":"102","author":"DA Palma","year":"2018","unstructured":"Palma, D. A. et al. Stereotactic ablative radiation therapy for the comprehensive treatment of oligometastatic tumors (SABR-COMET): results of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys. 102, S3\u2013S4. https:\/\/doi.org\/10.1016\/j.ijrobp.2018.06.105 (2018).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"68160_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000455683","volume":"33","author":"C Chiapponi","year":"2017","unstructured":"Chiapponi, C. et al. Oligometastatic disease in upper gastrointestinal cancer\u2014how to proceed?. Visc. Med. 33, 31\u201334. https:\/\/doi.org\/10.1159\/000455683 (2017).","journal-title":"Visc. Med."},{"key":"68160_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/bib\/bbr001","volume":"12","author":"RM Simon","year":"2011","unstructured":"Simon, R. M., Subramanian, J., Li, M. C. & Menezes, S. Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data. Brief. Bioinform. 12, 203\u2013214. https:\/\/doi.org\/10.1093\/bib\/bbr001 (2011).","journal-title":"Brief. Bioinform."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68160-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68160-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T13:26:23Z","timestamp":1670333183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-68160-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,9]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["68160"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-68160-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,9]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11259"}}